Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. It serves as a building block in the preparation of active pharmaceutical ingredients (APIs) targeting tyrosine kinases, which play a role in tumor growth and progression. Its structure allows for selective substitution reactions, enabling the introduction of functional groups needed for biological activity. Commonly employed in research and industrial settings for the production of targeted therapies in oncology.